Home Tools
Log in
Cart

Search Result

Search Results for " obesity-associated diabetes "

8

Compounds

Cat No. Product Name Synonyms Targets
T60047 V-0219 Glucagon Receptor
V-0219 is a positive allosteric modulator of GLP-1 and can be used in studies about obesity-associated diabetes.
T60047L V-0219 hydrochloride V-0219 hydrochloride(878453-71-5 Free base) Glucagon Receptor
V-0219 hydrochloride, an orally-active positive allosteric modulator (PAM) of the glucagon-like peptide-1 receptor (GLP-1R), is utilized in obesity-associated diabetes research.
T3283 Cetilistat ATL-962 Lipid
Cetilistat (ATL-962) is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of obesity and associated co-morbidities, including type 2 diabetes.
T4723 D-Tagatose D-(-)-Tagatose,d-tagatos Others , Endogenous Metabolite
D-Tagatose (D-(-)-Tagatose), a rare natural hexoketose, is an isomer of d-galactose. D-Tagatose occurs naturally in Sterculia setigera gum, and it is also found in small quantities in various foods such as sterilized and...
T39488 Relzomostat
Relzomostat is a MetAP2 inhibitor, specifically targeting methionine aminopeptidase 2. It holds potential in research concerning obesity, type 2 diabetes, and other conditions associated with obesity.
T40950 A3334
A3051, is a robust and orally active inhibitor of CXXC5-DVL with an IC 50 of 63.06 nM. Its applications include research into phenotypes associated with obesity, diabetes, and NASH that are induced by high fat diet (HFD)...
T81628 OB3
OB3, a leptin derivative, exhibits greater efficacy than leptin in diminishing obesity and diabetes in mouse models. Additionally, OB3 mitigates leptin-associated inflammation and proliferation in hepatocellular carcinom...
T74672 Sirtuin modulator 5
Sirtuin Modulator 5, a sirtuin modulating agent, activates SIRT1 with an efficacy marked by a DC50 value of less than 50 μM. It is applicable in enhancing cell longevity and is researched for its therapeutic potential in...
TargetMol